CN102198178A - Zhenrong Yinao capsules - Google Patents
Zhenrong Yinao capsules Download PDFInfo
- Publication number
- CN102198178A CN102198178A CN2011101350719A CN201110135071A CN102198178A CN 102198178 A CN102198178 A CN 102198178A CN 2011101350719 A CN2011101350719 A CN 2011101350719A CN 201110135071 A CN201110135071 A CN 201110135071A CN 102198178 A CN102198178 A CN 102198178A
- Authority
- CN
- China
- Prior art keywords
- yinao
- parts
- precious
- jiaonang
- rong
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to Zhenrong Yinao capsules capable of treating the symptoms of insufficiency of cerebral blood supply, memory decline, cerebral apoplexy sequela, brain functional degradation, encephalatrophy, insomnia and the like. The Zhenrong Yinao capsules comprise the following components in parts by weight: 12-30 parts of cistanche deserticola, 16-30 parts of red sage root, 1-3 parts of pearl, 3-6 parts of liquorice, 5-12 parts of wild jujube seed and 3-9 parts of magnolia vine fruit. The invention also provides a preparation method of the Zhenrong Yinao capsules.
Description
Technical field
The present invention relates to a kind of cerebral blood supply insufficiency, hypomnesis, apoplexy sequela, precious Rong's YINAO JIAONANG of symptoms such as brain function decline, brain atrophy, insomnia for the treatment of.
Background technology
21 century aged tendency of population and Senile disease brought stern challenge to us.Impel us to think deeply old people's health care issues such as health, disease again.Follow hard on aged tendency of population, the sickness rate of Senile disease also straight line rises, as alzheimer disease, senile encephalatrophy, hypomnesis etc.The characteristics of geratic period disease are: how sick 1 one people are, 2 atypical symptoms, 3 development are fast, easy multiple organs failure, 4 complication are many, 5 Drug tolerances are poor, 6 be subject at heart, the Nervous and Mental Factors influence, and exactly the current Western medicine of these characteristics and Chinese medicine is only to some symptoms effectively and other symptom is invalid, and shortcomings such as side effect is big are difficult to play satisfied curative effect, because of their inevitable side effect easily causes the property infringement of medicine source, it is little therefore to develop side effect, is suitable for old people's physiology and is the subject matter that modern medicine faces to the active drug of Senile disease.
Summary of the invention
Precious Rong's YINAO JIAONANG provided by the invention is by six kinds of synthetic pharmaceutical compositions of famous and precious mongolian medicine such as Herba Cistanches, Radix Salviae Miltiorrhizae, Margarita, Radix Glycyrrhizae, Semen Ziziphi Spinosae, Fructus Schisandrae Chinensis.Wherein:
Herba Cistanches: have desert Radix Ginseng good reputation, because of containing nerve growth factor similar activity material, and contain 2-caproyl eugenol glycoside, daucosterol and 15 seed amino acids all are the necessary nutrient substance of brain cell, and have the neuroprotective function.The herba cistanches pharmaceutical research thinks that it contains the plain glycosides A of Herba Cistanches, and B....G contains the D-mannose, β-glutamic acid, amber primary acid, micro-alkaloid.Think that from pharmacological research Herba Cistanches has: 1, raise immunity; 2, resisting fatigue, antioxidation, defying age, cold-resistant; 3, protection cardiac-cerebral ischemia; 4 brain-strengthening, functions such as the kidney invigorating.Mongolian medicine's theory is thought: alzheimer disease belongs to deficient syndrome more, and particularly heart kidney deficiency of spleen-QI, so Mongolian medicine theory is thought main kidney tonifying marrow facilitating, the reinforcing the heart spleen of holding concurrently.There is research to think that Herba Cistanches contains benzene hexanol glycosides compound, has the anti-senile dementia effect.
Radix Salviae Miltiorrhizae: be the root of labiate Radix Salviae Miltiorrhizae.1 chemical constituent main contains liposoluble constituent, comprise Tanshinone I, tanshinone, Tanshinone II B, Tanshinone I II ....Water soluble ingredient mainly contains danshensu, saivianic acid A, second, third.2, pharmacological action: can expand cardiovascular and cerebrovascular vessel, improve the anoxia tolerance, improve hemorheology, blood viscosity lowering, anticoagulant function.Especially tanshinone has protective effect to cerebral ischemia reperfusion injury, its mechanism may with reduce inflammatory reaction behind the ischemia-reperfusion, alleviate oxidative damage and to improve energy metabolism impairment relevant.There are some researches prove that TANSHINONES A can improve the learning and memory function of mice, can increase fourth ventricle in mice with vascular dementia cortex and hippocampus amino acid content, show very strong antioxidation.
Margarita: contain 18 seed amino acids, the chemical composition of Margarita is: CaCO391.6%, H2O and organic each 4%, glutamic acid 0.4%.Other aminoacid has: leucine (Leucine), methionine (Methionine), alanine (Alanine), glycine (Glycine), glutamic acid (Glutamic acid), aspartic acid (Aspartic acid) etc.In addition, these all are the important substance of protection brain cell and nutrition cerebral tissue also to contain 30 various trace elements, taurine, abundant vitamin, peptide class.Modern pharmacology research, the main component of Margarita has calcium carbonate, taurine, the trace element of needed by human body also contains the aminoacid of needed by human body.Its effect is as follows; Taurine; Can effectively regulate human central nervous and endocrine helps sleep.Glycine, Shen thiamine acid; Help delay senility, improve human endocrine, enhance metabolism, health invigorating.Margarita also contains various trace elements; Magnesium, aluminum, copper, ferrum, sodium, zinc, titanium, strontium, silver.Its glycine and alanine are maximum.
Radix Glycyrrhizae: main component: kind of Radix Glycyrrhizae pyrite compounds and 60 kinds of liquorice flavonoids compounds and legumin class surplus from Radix Glycyrrhizae, isolating 160 at present, 18 seed amino acids, and multiple alkaloid, estrogen and multiple organic acid.Pharmacological action: 1, antiinflammatory is one of main effect of glycyrrhizic acid, and is inhibited to immune inflammation; 2, wherein a kind of chemical compound of flavonoid-different Radix Glycyrrhizae class has lax blood vessel, antioxidation, and anticoagulant, antiviral, antitumor and multiple pharmacological effect have protective effect to the hypoxic-ischemic of brain.
Semen Ziziphi Spinosae: chemical constituent mainly contains jujuboside A, B and flavone compound.Pharmacological action; Calmness, syngignoscism also has blood fat reducing, antiplatelet aggregation, lipoid peroxidization resistant.Experimental results show that; Semen Ziziphi Spinosae oil is cholesterol reducing obviously, low density lipoprotein, LDL and triglyceride level, the ratio of high density lipoprotein increasing and low-density lipoprotein cholesterol.Pharmacological research shows; Semen Ziziphi Spinosae energy raise immunity, its hexanol extract strengthens the phagocytic function of mononuclear phagocyte.Strengthen delayed hypersensitivity and the energy antagonism CPA of mice, cause the inhibition of the delayed hypersensitivity of mice.Experimental results show that Semen Ziziphi Spinosae has protective effect to the cerebral ischemia infringement.
Fructus Schisandrae Chinensis: extracting solution has inhibitory action to brain SOD, and malonaldehyde (MDA) level can point out the protection cerebral tissue to the lipid peroxidation injury effect.Have the effect of obvious removing free radical and suppress lipid peroxidation through Fructus Schisandrae Chinensis and active ingredient such as schisandrin B SALLRSIPA SAL ADNF-9 schizronol schisanhenol etc., its mechanism of action can suppress the generation of oxygen-derived free radicals on the one hand, but antagonism oxygen-derived free radicals in addition.
The hypomnesis that precious Rong's YINAO JIAONANG provided by the invention causes insomnia, forgetful, cerebral blood supply insufficiency, cerebral trauma, symptoms such as brain function decline have better curative effect, and it is little to have consumption, absorb slowly, lasting medicine, the curative effect height, side effect is little, takes the characteristics that are suitable for the geratic period disease with grade easy to carry.
It is (by weight) that components compatibility in the precious Rong's YINAO JIAONANG of the present invention closes: Herba Cistanches 12-30, Radix Salviae Miltiorrhizae 6-30, Margarita 1-3, Radix Glycyrrhizae 3-6, Semen Ziziphi Spinosae 5-12, Fructus Schisandrae Chinensis 3-9.
The compatibility relationship of the mongolian medicine composition in the precious Rong's YINAO JIAONANG of the present invention is preferably (by weight): Herba Cistanches 30, Radix Salviae Miltiorrhizae 30, Margarita 3, Radix Glycyrrhizae 6, Semen Ziziphi Spinosae 12, Fructus Schisandrae Chinensis 9.
The precious Rong's YINAO JIAONANG of the present invention can be made various pharmaceutical dosage forms according to method well known in the art, for example capsule, tablet, powder etc., and preferably, pharmaceutical composition of the present invention is a kind of capsule.
The preparation method of the precious Rong's YINAO JIAONANG of the present invention is to prepare raw material, drying according to described weight portion, be ground into fine powder, use the lixiviate of water 3 hours of 8 times of amounts then, obtain first-time filtrate, and then with the water secondary lixiviate of 10 times of amounts 2 hours, obtain secondary filtrate, merge filtrate twice, be concentrated into the thick paste of temperature 40-80 ℃ following relative density 1.3-1.5, dry in vacuum drying oven then, be ground into fine powder, make capsule, powder at last or be pressed into tablet.
The specific embodiment
Embodiment 1
Prepare raw material, Herba Cistanches 12, Radix Salviae Miltiorrhizae 6, Margarita 3 by following weight portion, Radix Glycyrrhizae 3, Semen Ziziphi Spinosae 5, Fructus Schisandrae Chinensis 3, mix, drying is ground into fine powder, use the lixiviate of water 3 hours of 8 times of amounts then, obtain first-time filtrate, and then with the water secondary lixiviate of 10 times of amounts 2 hours, obtain secondary filtrate, merge filtrate twice, be concentrated into the thick paste of temperature 40-80 ℃ of following relative density 1.3, dry in vacuum drying oven then, be ground into fine powder, make capsule at last.
Embodiment 2
Prepare raw material, Herba Cistanches 18, Radix Salviae Miltiorrhizae 12, Margarita 2 by following weight portion, Radix Glycyrrhizae 5, Semen Ziziphi Spinosae 10, Fructus Schisandrae Chinensis 4, mix, drying is ground into fine powder, use the lixiviate of water 3 hours of 8 times of amounts then, obtain first-time filtrate, and then with the water secondary lixiviate of 10 times of amounts 2 hours, obtain secondary filtrate, merge filtrate twice, be concentrated into the thick paste of temperature 40-80 ℃ of following relative density 1.4, dry in vacuum drying oven then, be ground into fine powder, make capsule at last.
Embodiment 3
Prepare raw material, Herba Cistanches 30, Radix Salviae Miltiorrhizae 30, Margarita 3 by following weight portion, Radix Glycyrrhizae 6, Semen Ziziphi Spinosae 12, Fructus Schisandrae Chinensis 9, mix, drying is ground into fine powder, use the lixiviate of water 3 hours of 8 times of amounts then, obtain first-time filtrate, and then with the water secondary lixiviate of 10 times of amounts 2 hours, obtain secondary filtrate, merge filtrate twice, be concentrated into the thick paste of temperature 40-80 ℃ of following relative density 1.5, dry in vacuum drying oven then, be ground into fine powder, make capsule at last.
Embodiment 4 (curative effect data)
Obtain product with the preferred component proportioning of capsule preparations of the present invention and carry out clinical examination, the 0.3g/ capsule, one time three, three times on the one, 30 days courses of treatment.This medicine is to shown in the following tabulation lattice of curative effect of various disease and each age group thereof: wherein said effectively, produce effects, healing, invalid standard be according to clinical neurologic deficit degree standards of grading: 1. cure: functional impairment scoring minimizing 91%-100%, invalid degree is 0 grade, 2. produce effects: the functional impairment scoring reduces 46%-90%, invalid degree is the 1-3 level, 3. effectively: the functional impairment scoring reduces 18%-45%, and is 4. invalid: the functional impairment scoring reduces less than 17% or increases or death.
1. the preceding patient of treatment has difficulty falling asleep, and awakening is often slept and shakiness, can not sleep again, and wake up too early morning, can not fall asleep night, and daytime, lethargic and drowsy state was not had enough sleep 5 hours, and history of repeated attack is arranged, and insomniac due to eliminating spirit and the severe organic disease.Treatment back clinical cure: recover the length of one's sleep normal or nighttime sleep time more than 6 hours, sleep is dull, and the back of waking up is hale and hearty.Produce effects: sleep is clearly better, and has increased by 3 hours the length of one's sleep, and Depth of sleep increases.Effectively: sx, the length of one's sleep, more preceding increase less than was 3 hours.Invalid: insomnia nothing in treatment back is obviously improved or the person of increasing the weight of.
Table 1 couple insomniac's curative effect (totally 60 examples)
2. before the cerebral blood supply insufficiency patient treatment: dizzy, nauseating, vomiting, uncomfortable in chest, headache, tinnitus etc. are expanded in numb limbs and tense tendons or acid.And the cranium of passing through is multispectral reins in ultrasonic examination, and vertebral artery bilateral blood supply insufficiency and carotid artery blood supply insufficiency are all arranged.The treatment back cures: above-mentioned symptom disappears and the multispectral ultrasonic examination blood vessel of reining in of cranium recovers normal.Produce effects: above-mentioned symptom disappears substantially, but reins in ultrasonic examination and not recover normal through cranium is multispectral.Effectively: above-mentioned symptom alleviates, but does not disappear, and the cranium of passing through is multispectral reins in ultrasonic examination with before treating.Invalid: above-mentioned symptom does not alleviate or increases the weight of.The cranium of passing through is multispectral reins in ultrasonic examination with before treating.
Table 2 couple cerebral blood supply insufficiency patient's curative effect (totally 52 examples)
3. the patient has mind clear before the treatment, and orientation force is poor, and memory (recent, long term) obviously goes down, and computing power is poor, bradykinesia; The treatment back cures: patient's memory, orientation force, computing power etc. all recover normal.Produce effects: cardinal symptom disappears substantially, and is conscious, and orientation force is sound, and it is correct to answer a question, and is quick on the draw; Effectively: answering a question is in the main true, but bradykinesia, intelligence and memory still have partial impairment; Invalid: cardinal symptom does not have change or PD.
Table 3 couple forgetful patient's curative effect (totally 45 examples)
Model case
Wang Quanzhong, the man, 50 years old, difficulty falling asleep, awakening is often slept and shakiness, can not sleep again, does not have enough sleep 5 hours, and the medical history of showing effect repeatedly has 1 year, goes to a doctor in outpatient service on February 5th, 2007.Give this medicine and be aided with essential drug and treat by last method, 2 week the back recover normal the lengths of one's sleep.
Wen Guizhen, woman, 76 years old; The peasant; Main cause is slow in action, and hypomnesis surplus outpatient service in 1 year is gone to a doctor.Nos obvious inducement occurred taking action ineffective before patient 1 year was surplus, and hypomnesis was often looked for loseing house in nearly 1 month, and near, at a specified future date memory obviously goes down.Department of neurology is had a medical check-up: patient's sanity, memory, computing power, orientation force obviously go down.Outpatient service gives this medicine and is aided with essential drug and treats by last method, and symptom is clearly better soundly to orientation force after 30 days, and it is correct to answer a question, and is quick on the draw.
Wang Meihua, the patient, the women, 69 years old, the retired worker, outpatient service on May 7th, 2006 is gone to a doctor.WA occurs suddenly dizzyly before 3 days, looks the thing rotation, aggravation when cervical region is movable, the nausea of feeling sick, discomfort uncomfortable in chest, the stiff pain of neck.The back symptom of having a rest is not alleviated, and comes my institute's diagnosis and treatment.Cervical spondylosis is arranged, dizzy repeatedly history of attack 3 years.Body is looked into: blood pressure 18/12Kpa.The obvious tenderness of cervical vertebra.The rombergism positive.Enlarged tongue, tongue are greasy in vain, stringy and rolling pulse.Blood biochemical investigation: T-CHOL 5.10mmol/L, triglyceride 1.99mmol/L.Cervical vertebra X-ray film: cervical vertebra regression.Transcranial doppler shows: cerebral arteriosclerosis, right side vertebral artery, right side anterior cerebral artery blood supply insufficiency.Diagnosis: vertebro-basilar artery insufficiency.Give this medicine and be aided with essential drug and treat by last method, medication took a turn for the better after 3 days, had fully recovered in the time of 15 days.
Claims (3)
1. precious Rong's YINAO JIAONANG is characterized in that making its active component raw material medicine and is made up of the component of following weight proportioning: Herba Cistanches 12-30, Radix Salviae Miltiorrhizae 6-30, Margarita 1-3, Radix Glycyrrhizae 3-6, Semen Ziziphi Spinosae 5-12, Fructus Schisandrae Chinensis 3-9.
2. according to precious Rong's YINAO JIAONANG of claim 1, wherein make its active component raw material medicine and form: Herba Cistanches 30, Radix Salviae Miltiorrhizae 30, Margarita 3, Radix Glycyrrhizae 6, Semen Ziziphi Spinosae 12, Fructus Schisandrae Chinensis 9 by the component of following weight proportioning.
3. according to the preparation method of the arbitrary precious Rong's YINAO JIAONANG of claim 1-2, it is characterized in that preparing crude drug, drying according to described weight portion, be ground into fine powder, use the lixiviate of water 3 hours of 8 times of amounts then, obtain first-time filtrate, and then with the water secondary lixiviate of 10 times of amounts 2 hours, obtain secondary filtrate, merge filtrate twice, be concentrated into the thick paste of temperature 40-80 ℃ following relative density 1.3-1.5, dry in vacuum drying oven then, be ground into fine powder, make capsule at last.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101350719A CN102198178B (en) | 2011-05-24 | 2011-05-24 | Traditional Chinese medicine capsule for treating insomnia, amnesia, insufficient blood supply, and the like |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101350719A CN102198178B (en) | 2011-05-24 | 2011-05-24 | Traditional Chinese medicine capsule for treating insomnia, amnesia, insufficient blood supply, and the like |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102198178A true CN102198178A (en) | 2011-09-28 |
| CN102198178B CN102198178B (en) | 2013-01-30 |
Family
ID=44659333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101350719A Expired - Fee Related CN102198178B (en) | 2011-05-24 | 2011-05-24 | Traditional Chinese medicine capsule for treating insomnia, amnesia, insufficient blood supply, and the like |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102198178B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104873679A (en) * | 2012-02-01 | 2015-09-02 | 李庭栋 | A potato and cistanche-containing life-protecting decoction |
| CN111729040A (en) * | 2020-07-10 | 2020-10-02 | 孟凡云 | A teabag with sleep improving effect and its preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101306156A (en) * | 2008-06-14 | 2008-11-19 | 王跃进 | Yixinfumai capsule |
| CN101757268A (en) * | 2008-11-08 | 2010-06-30 | 陈志锋 | Traditional Chinese medicine composite for treating Insomnia and lethargy and preparation method thereof |
-
2011
- 2011-05-24 CN CN2011101350719A patent/CN102198178B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101306156A (en) * | 2008-06-14 | 2008-11-19 | 王跃进 | Yixinfumai capsule |
| CN101757268A (en) * | 2008-11-08 | 2010-06-30 | 陈志锋 | Traditional Chinese medicine composite for treating Insomnia and lethargy and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 《河南中医学院学报》 20031120 胡怀强 近年中医药治疗中风后遗症进展 83-85 1-3 第18卷, 第06期 * |
| 《辽宁中医药大学学报》 20090205 黄燕凤等 中医药治疗老年失眠症的临床研究进展 76-77 1-3 第11卷, 第02期 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104873679A (en) * | 2012-02-01 | 2015-09-02 | 李庭栋 | A potato and cistanche-containing life-protecting decoction |
| CN111729040A (en) * | 2020-07-10 | 2020-10-02 | 孟凡云 | A teabag with sleep improving effect and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102198178B (en) | 2013-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101485445B (en) | Health care food | |
| CN103493941B (en) | A kind of Weight-reducing health-care tea and preparation method thereof | |
| CN102640829B (en) | Tea paste with myocardial ischemia function improving function and preparation method of tea paste | |
| CN104998098B (en) | It is a kind of to improve the solid beverage slept and preparation method | |
| CN102640822B (en) | Health care tea paste and preparation method of health care tea paste | |
| CN104388265B (en) | A kind of kidney-nourishing health tonic wine and preparation method thereof | |
| CN101632760A (en) | Method for preparing tea for relieving uneasiness | |
| CN101612315A (en) | A kind of compound Chinese medicinal preparation that is used to adjust function of human body | |
| CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
| CN102335330A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN102640821B (en) | Solid instant health care tea and preparation method of solid instant health care tea | |
| CN102526217A (en) | Formula of health-care medicine with functions of strengthening immunity and promoting sleep | |
| CN102106537B (en) | Compound many-flower solomonseal rhizome capsules and preparation method thereof | |
| CN103053767B (en) | Method for preparing desert cistanche health-care nutrition tea | |
| CN102198178B (en) | Traditional Chinese medicine capsule for treating insomnia, amnesia, insufficient blood supply, and the like | |
| CN104474472A (en) | Broadleaf holly leaf buccal tablet capable of reducing high blood pressure, high blood lipid and high blood glucose and production method of buccal tablet | |
| CN103463625A (en) | Nutraceutical for nourishing heart and replenishing blood | |
| CN105661505A (en) | Nutrient preparation for alleviating chronic fatigue and preparation method of nutrient preparation | |
| CN103520302B (en) | Sea-buckthorn leaf anti-fatigue capsule and preparation method thereof | |
| CN104432052A (en) | Health capsules capable of resisting fatigue and preventing aging and preparation method thereof | |
| CN104162005A (en) | Traditional Chinese medicine for treating epilepsy | |
| CN102908396A (en) | Chinese medicinal composition for promoting sleeping and preparation method thereof | |
| CN102813719A (en) | Traditional Chinese medicine capsule for treating anhypnia | |
| CN102579816A (en) | Brain-invigorating tablets and preparation method thereof | |
| CN102973687B (en) | Oral liquid for regulating female hormonal balance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130130 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |